← Back to Search

Behavioral Intervention

Packaging Imagery for Cannabis Use

N/A
Waitlist Available
Led By Beth Reboussin, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after exposure to product packaging - up to 1 min
Awards & highlights

Summary

This trial aims to understand how people's opinions about cannabis edibles are influenced by the packaging images on the products.

Who is the study for?
This trial is for US residents aged 18-65 who have not participated in a related previous experiment. It includes both past year cannabis users and non-users, with specific participation quotas for individuals identifying as Hispanic (up to 16%) or Black/African American (up to 13%).
What is being tested?
The study aims to evaluate how packaging imagery on cannabis edibles affects people's perception of the product's appeal, potential harm, and their willingness to try it. Participants will be exposed to products with or without such imagery.
What are the potential side effects?
Since this trial involves perceptions rather than ingestion of substances, traditional physical side effects are not applicable. However, exposure to the packaging could influence attitudes towards cannabis use.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after exposure to product packaging - up to 1 min
This trial's timeline: 3 weeks for screening, Varies for treatment, and after exposure to product packaging - up to 1 min for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Harm Perceptions (Absolute) Scoring
Product Appeal Scoring
Willingness to Try Product Scoring
Secondary outcome measures
Appeal to Children Scoring
Harm Perceptions (Relative) Scoring
Perception of Quality Scoring

Trial Design

5Treatment groups
Experimental Treatment
Group I: No Imagery (Control)Experimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) without any added packaging imagery.
Group II: Nature ImageryExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with package imagery in a nature theme.
Group III: Medical ImageryExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with package imagery in a medical theme.
Group IV: Flavor ImageryExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with package imagery in a flavor theme.
Group V: Animal ImageryExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with package imagery in an animal theme.

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,253 Previous Clinical Trials
1,009,682 Total Patients Enrolled
1 Trials studying Cannabis Use
2,731 Patients Enrolled for Cannabis Use
National Institute on Drug Abuse (NIDA)NIH
2,503 Previous Clinical Trials
2,624,333 Total Patients Enrolled
29 Trials studying Cannabis Use
5,596 Patients Enrolled for Cannabis Use
Beth Reboussin, PhDPrincipal InvestigatorWake Forest University Health Sciences
1 Previous Clinical Trials
2,731 Total Patients Enrolled
1 Trials studying Cannabis Use
2,731 Patients Enrolled for Cannabis Use
~833 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top